Septic Arthritis & Prosthetic Joint Infections
Comprehensive emergency evaluation and protocolized management of acute monoarthritis and joint infections: anatomical approaches to diagnostic arthrocentesis for the knee, shoulder, elbow, and ankle; rigorous synovial fluid analysis (cell count, differential, Gram stain, crystal microscopy under polarized light); native joint diagnostic thresholds (> 50,000 WBC/mcL with > 75% PMNs) versus the dramatically reduced cell count thresholds for Prosthetic Joint Infections (PJI: > 1,100 to 3,000 WBC/mcL); co-existent septic arthritis and gout; targeted intravenous empiric antimicrobial regimens; and urgent orthopedic surgical arthrotomy indications.
Resuscitation Quick Actions • First 2 Minutes
Arthrocentesis Before Antibiotics
Perform sterile joint aspiration immediately to obtain synovial fluid for cell count, differential, Gram stain, culture, and crystals before infusing antibiotics
Native Joint WBC Threshold
Synovial WBC > 50,000/mcL with > 75% PMNs strongly suggests septic arthritis (although counts > 20,000/mcL in high-risk hosts mandate treatment)
Prosthetic Joint WBC Threshold
DO NOT use native thresholds! Synovial WBC > 1,100 to 3,000/mcL (or > 65-80% PMNs) indicates Prosthetic Joint Infection (PJI) -> Stat Ortho consult
Empiric Native Joint Regimen
Vancomycin 15-20 mg/kg IV q12h (covers MRSA) PLUS Ceftriaxone 2 g IV daily (covers N. gonorrhoeae and Gram-negatives)
Pseudomonas High-Risk Hosts
IV drug users, elderly, immunocompromised -> Replace Ceftriaxone with Cefepime 2 g IV q8h or Piperacillin-Tazobactam 4.5 g IV
Co-Existence Warning
Identifying monosodium urate or CPPD crystals DOES NOT exclude bacterial infection; if synovial WBC is high or clinical sepsis is present, treat for septic arthritis concurrently
Bottom-Line Clinical Pearl
Acute septic arthritis is a true orthopedic emergency that causes irreversible enzymatic destruction of articular cartilage (chondrolysis) within 24 to 48 hours; perform diagnostic arthrocentesis prior to administering systemic antibiotics. Synovial fluid WBC > 50,000/mcL with > 75% neutrophils is classic for native septic arthritis, but up to 30-50% of confirmed septic joints present with counts < 50,000/mcL, and crystal identification does NOT rule out co-existing septic arthritis (up to 5% have simultaneous infection and gout). In patients with a joint replacement, NEVER wait for 50,000 cells: a prosthetic joint synovial WBC > 1,100 to 3,000/mcL is diagnostic of Prosthetic Joint Infection (PJI).
Bacterial seeding of the synovial space occurs predominantly via hematogenous spread, owing to the high vascularity of the synovial membrane and absence of a protective basement membrane. Once bacteria enter the joint, bacterial toxins and host neutrophil proteases and collagenases cause irreversible articular chondrolysis within 24 to 48 hours, culminating in joint destruction and permanent functional disability.
| Patient Population | Predominant Pathogens | Clinical Characteristics |
|---|---|---|
| Adults (Overall: > 50-60% of Cases) | Staphylococcus aureus (MSSA and MRSA) followed by Streptococcus species (Group A, B, and S. pneumoniae). | Acute onset, excruciating monoarticular pain, tense joint effusion, severe restriction of passive and active range of motion, inability to bear weight. The knee is involved in > 50% of cases, followed by hip, shoulder, ankle, and wrist. |
| Young, Sexually Active Adults | Neisseria gonorrhoeae (Disseminated Gonococcal Infection (DGI)). | Classic triad: tenosynovitis (wrist/ankles), polyarthralgias, and painless necrotic/pustular skin lesions on extremities; or purulent monoarthritis. Blood cultures frequently negative; obtain mucosal swabs (urethral, cervical, pharyngeal, rectal) for NAAT. |
| IV Drug Users (IVDU) & Immunocompromised | Pseudomonas aeruginosa, Enterobacteriaceae, Serratia marcescens, MRSA. | High propensity for axial and fibrocartilaginous joints: sternoclavicular, sacroiliac, manubriosternal, and pubic symphysis joints. |
| Prosthetic Joints (Early: < 3 months) | Staphylococcus aureus, Gram-negative bacilli (Pseudomonas, E. coli). | Acquired intraoperatively during arthroplasty; acute fulminant wound drainage, fever, erythema, and prosthetic looseness. |
| Prosthetic Joints (Delayed: 3 to 24 months) | Coagulase-Negative Staphylococci (Staphylococcus epidermidis), Cutibacterium (Propionibacterium) acnes. | Indolent biofilm formation on metal/polyethylene hardware; persistent dull joint ache, early loosening without overt systemic fever. |
| Target Joint | Recommended Needle & Anatomical Landmark | Technique & Pitfalls |
|---|---|---|
| Knee Joint (Most Common) | 18- or 20-gauge, 1.5-inch needle. Landmark: Superolateral approach (1 cm superior and 1 cm lateral to the superolateral pole of the patella). | Insert needle horizontally behind the patella into the suprapatellar bursa. Compress the bursa with the non-dominant hand ('milking the joint') to maximize fluid aspiration. Avoid inserting through overlying cellulitic skin. |
| Shoulder Joint (Glenohumeral) | 20-gauge, 1.5- to 2.5-inch needle. Landmark: Posterior approach (2 cm inferior and 1 cm medial to the posterolateral acromion corner). | Aim needle anteriorly toward the coracoid process. Ultrasound guidance significantly improves success rates. |
| Ankle Joint (Tibiotalar) | 20- or 22-gauge, 1.5-inch needle. Landmark: Anteromedial approach (medial to the tibialis anterior tendon, lateral to the medial malleolus). | Plantigrade foot. Avoid the anterior tibial artery and deep peroneal nerve located between the extensor hallucis longus and tibialis anterior. |
| Wrist Joint (Radiocarpal) | 22-gauge, 1-inch needle. Landmark: Dorsal approach between the extensor digitorum and extensor pollicis longus (Lister's tubercle). | Traction and slight palmar flexion. Avoid radial artery. |
| Parameter | Normal Synovial Fluid | Non-Inflammatory (OA) | Inflammatory (Gout/Pseudogout) | Native Septic Arthritis | Prosthetic Joint Infection (PJI) |
|---|---|---|---|---|---|
| Clarity & Color | Transparent, clear | Transparent, pale yellow | Translucent/opaque, yellow-cloudy | Opaque, turbid, purulent ('frank pus') | Turbid, purulent, serosanguinous |
| White Blood Cell (WBC) Count | < 200/mcL | 200 to 2,000/mcL | 2,000 to 50,000/mcL (can exceed 100k) | > 50,000/mcL (typically > 75k–100k; up to 30% are < 50k) | > 1,100 to 3,000/mcL (depending on post-op timing; NEVER require 50k!) |
| Polymorphonuclear (PMN) % | < 25% | < 25% | > 50% to 75% | > 75% to 90% | > 65% to 80% |
| Polarized Microscopy | No crystals | No crystals | Gout: Needle-shaped, negatively birefringent (yellow when parallel to axis) Pseudogout: Rhomboid-shaped, positively birefringent (blue when parallel) | Usually negative, BUT crystals and bacteria frequently co-exist! | Negative (unless metallosis/polyethylene wear debris) |
| Gram Stain & Culture | Negative | Negative | Negative | Gram stain positive in 50-70%; culture positive in 70-90% | Gram stain often negative (biofilm); send fluid for extended 14-day cultures |
| Clinical Scenario | First-Line Empiric Intravenous Regimen | Orthopedic Surgical Interventions |
|---|---|---|
| Native Joint (Standard Host) | 1. Vancomycin 15–20 mg/kg IV q12h (trough 15-20 mcg/mL; covers MRSA) PLUS 2. Ceftriaxone 2 g IV daily (covers N. gonorrhoeae and Gram-negatives). (If low MRSA risk and patient young: Cefazolin 2 g IV q8h + Ceftriaxone). | Urgent Orthopedic Surgery consultation for arthroscopic washout or open arthrotomy. Repeated needle aspiration is reserved only for select small joints or patients too unstable for the OR. |
| Native Joint (IVDU, Diabetic, Immunocompromised) | Antipseudomonal & MRSA Coverage: 1. Vancomycin 15–20 mg/kg IV q12h PLUS 2. Cefepime 2 g IV q8h OR Piperacillin-Tazobactam 4.5 g IV q6h OR Meropenem 1 g IV q8h. | Emergent surgical drainage. Serial joint lavages in the operating room are typically required. |
| Prosthetic Joint Infection (PJI) | Do NOT initiate antibiotics before orthopedic joint aspiration in the OR unless septic shock is present. If critically septic: Vancomycin 15–20 mg/kg IV PLUS Cefepime 2 g IV. | Orthopedic operative management: DAIR (Debridement, Antibiotics, and Implant Retention) with modular component exchange (for acute PJI < 3-6 weeks) OR Two-stage revision arthroplasty with antibiotic spacer placement. |
The Prosthetic Joint Cell Count Trap & The Co-Existent Gout Hazard
Never evaluate a patient with a total knee or hip replacement using native joint synovial criteria! In a prosthetic joint, the presence of metal and polyethylene foreign bodies dramatically reduces the host's bacterial clearance and lowers the inflammatory threshold: a synovial WBC count of only 1,500 to 3,000/mcL represents an acute Prosthetic Joint Infection (PJI). Waiting for the cell count to reach 50,000/mcL will lead to missed infections, irreversible hardware colonization by staphylococcal biofilms, and catastrophic osteomyelitis. Furthermore, in native joints, identifying monosodium urate crystals on polarized microscopy DOES NOT rule out septic arthritis: between 2% and 5% of patients presenting with acute gout or pseudogout harbor simultaneous bacterial infection. If the synovial fluid WBC is markedly elevated (> 50,000/mcL), the joint is purulent, or the patient has systemic fever or elevated inflammatory markers, treat aggressively with empiric IV antibiotics and orthopedic consultation while cultures incubate.
Test Your Septic Arthritis & Prosthetic Joint Infections Clinical Acumen
Directly launch an active-recall practice block from our 8,400+ validated COMLEX Level 1, 2-CE & 3 board question bank with complete explanations.
Related Emergency Protocols & Differentials
Monoarthritis & Rheumatologic Emergencies
Crystal arthropathies, gout, and systemic rheumatology.
Open Protocol Related EM ProtocolSexually Transmitted Infections, PID & DGI
Disseminated gonococcal arthritis-dermatitis syndrome.
Open Protocol Related EM ProtocolOrthopedic Emergencies, Fractures & Splinting
Open fractures, acute compartment syndrome, and reductions.
Open Protocol